NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Stock Information for NovaBay Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NovaBay Pharmaceuticals Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, NBY, ARC on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm
NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.'s Avenova Brand and Business Is Fair to Shareholders
Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
Niobium-Titanium Alloy Demonstrates Its Strong Market Potential in the Fabrication of Fuel Cells
NioBay Metals Receives Authorization to Drill on Zone 1 of its Foothills Property
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.